MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 218 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,766,000 | -11.2% | 469,032 | -19.4% | 0.01% | -25.0% |
| Q3 2020 | $9,877,000 | -24.8% | 581,696 | +3.1% | 0.02% | -33.3% |
| Q2 2020 | $13,138,000 | +859.7% | 564,096 | +246.1% | 0.02% | +500.0% |
| Q1 2020 | $1,369,000 | -46.5% | 163,000 | -37.7% | 0.00% | -33.3% |
| Q4 2019 | $2,558,000 | +21.1% | 261,772 | +17.6% | 0.01% | +20.0% |
| Q3 2019 | $2,113,000 | -7.0% | 222,622 | +16.4% | 0.01% | 0.0% |
| Q2 2019 | $2,273,000 | -39.4% | 191,298 | -10.2% | 0.01% | -44.4% |
| Q1 2019 | $3,753,000 | -25.7% | 213,094 | -26.7% | 0.01% | -30.8% |
| Q4 2018 | $5,049,000 | +92.4% | 290,859 | +65.2% | 0.01% | +116.7% |
| Q3 2018 | $2,624,000 | +136.0% | 176,105 | +151.7% | 0.01% | +100.0% |
| Q2 2018 | $1,112,000 | +25.1% | 69,965 | +11.8% | 0.00% | +50.0% |
| Q1 2018 | $889,000 | -17.3% | 62,585 | -18.5% | 0.00% | -33.3% |
| Q4 2017 | $1,075,000 | – | 76,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |